​

Sabra Health Care REIT (SBRA) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

SBRA Stock Forecast

Sabra Health Care REIT (SBRA) stock forecast, based on 29 Wall Street analysts, predicts a 12-month average price target of $22.50, with a high of $25.00 and a low of $21.00. This represents a 5.53% increase from the last price of $21.32.

$10 $13 $16 $19 $22 $25 High: $25 Avg: $22.5 Low: $21 Last Closed Price: $21.32

SBRA Stock Rating

Sabra Health Care REIT stock's rating consensus is Hold, based on 29 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 11 Buy (37.93%), 16 Hold (55.17%), 2 Sell (6.90%), and 0 Strong Sell (0.00%).

Hold
Total 29 0 2 16 11 Strong Sell Sell Hold Buy Strong Buy

SBRA Price Target Upside V Benchmarks

TypeNameUpside
StockSabra Health Care REIT5.53%
SectorReal Estate Stocks 9.27%
IndustryHealthcare REIT Stocks5.51%

Price Target Trends

1M3M12M
# Anlaysts4817
Avg Price Target$22.75$22.00$21.41
Last Closing Price$21.32$21.32$21.32
Upside/Downside6.71%3.19%0.42%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jul, 26149-115
Jun, 26157--13
May, 26157--13
Apr, 26158--14
Mar, 26158--14
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jul 22, 2026UBS$25.00$21.8714.31%17.26%
Jul 22, 2026Wesley GolladayRobert W. Baird$23.00$22.044.36%7.88%
Jul 08, 2026Truist Financial$22.00$20.069.67%3.19%
Jul 07, 2026Barclays$21.00$19.736.44%-1.50%
Jun 18, 2026UBS$19.00$17.965.79%-10.88%
May 21, 2026Scotiabank$22.00$20.815.72%3.19%
May 13, 2026Michael GoldsmithUBS$22.00$20.974.91%3.19%
May 11, 2026Richard AndersonCantor Fitzgerald$22.00$20.756.02%3.19%
Feb 19, 2026Michael GoldsmithUBS$21.00$20.243.75%-1.50%
Feb 17, 2026Richard AndersonCantor Fitzgerald$21.00$20.174.12%-1.50%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jul 22, 2026Deutsche BankBuyBuyhold
Jul 22, 2026CitigroupOutperformOutperformhold
Jul 22, 2026CitigroupMarket OutperformMarket Outperformhold
Jun 22, 2026CitigroupBuyNeutraldowngrade
May 21, 2026ScotiabankSector PerformSector Performhold
May 13, 2026UBSNeutralNeutralhold
May 11, 2026Cantor FitzgeraldNeutralNeutralhold
Mar 26, 2026Wells FargoOverweightOverweighthold
Mar 02, 2026ScotiabankSector PerformSector Performhold
Feb 19, 2026UBSNeutralNeutralhold

Financial Forecast

EPS Forecast

Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.52$-0.34$0.06$0.54$0.64---
Avg Forecast$-0.28$0.14$0.12$0.51$0.70$0.75$0.79-
High Forecast$-0.26$0.15$0.12$0.51$0.72$0.81$0.84-
Low Forecast$-0.29$0.13$0.12$0.49$0.68$0.72$0.74-
Surprise %85.71%-342.86%-50.00%5.88%-8.57%---

Revenue Forecast

$500M $600M $700M $800M $900M $1B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$569.54M$624.81M$647.51M$703.24M$774.63M---
Avg Forecast$581.47M$599.63M$647.02M$686.97M$739.76M$782.38M$866.17M$914.11M
High Forecast$604.60M$629.79M$651.41M$688.31M$756.24M$786.45M$898.19M$958.63M
Low Forecast$549.08M$555.79M$644.70M$685.03M$722.35M$778.30M$834.15M$870.26M
Surprise %-2.05%4.20%0.08%2.37%4.71%---

Net Income Forecast

$-250M $-160M $-70M $20M $110M $200M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-113.26M$-77.61M$13.76M$126.71M$155.61M---
Avg Forecast$-141.10M$-155.95M$13.76M$117.15M$162.57M$185.05M$189.97M-
High Forecast$-94.74M$-105.10M$18.24M$119.22M$166.93M$188.21M$195.55M-
Low Forecast$-187.47M$-206.81M$9.27M$115.08M$158.20M$167.30M$172.44M-
Surprise %-19.73%-50.24%-8.17%-4.28%---

SBRA Forecast FAQ

Is Sabra Health Care REIT stock a buy?

Sabra Health Care REIT stock has a consensus rating of Hold, based on 29 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 11 Buy, 16 Hold, 2 Sell, and 0 Strong Sell, reflecting a consensus that Sabra Health Care REIT is a neutral investment for most analysts.

What is Sabra Health Care REIT's price target?

Sabra Health Care REIT's price target, set by 29 Wall Street analysts, averages $22.5 over the next 12 months. The price target range spans from $21 at the low end to $25 at the high end, suggesting a potential 5.53% change from the previous closing price of $21.32.

How does Sabra Health Care REIT stock forecast compare to its benchmarks?

Sabra Health Care REIT's stock forecast shows a 5.53% upside, underperforming the average forecast for the real estate stocks sector (9.27%) and outperforming the healthcare reit stocks industry (5.51%).

What is the breakdown of analyst ratings for Sabra Health Care REIT over the past three months?

  • July 2026: 6.67% Strong Buy, 26.67% Buy, 60.00% Hold, 0% Sell, 6.67% Strong Sell.
  • June 2026: 7.69% Strong Buy, 38.46% Buy, 53.85% Hold, 0% Sell, 0% Strong Sell.
  • May 2026: 7.69% Strong Buy, 38.46% Buy, 53.85% Hold, 0% Sell, 0% Strong Sell.

What is Sabra Health Care REIT’s EPS forecast?

Sabra Health Care REIT's average annual EPS forecast for its fiscal year ending in December 2026 is $0.75, marking a 17.19% increase from the reported $0.64 in 2025. Estimates for the following years are $0.79 in 2027, and $0 in 2028.

What is Sabra Health Care REIT’s revenue forecast?

Sabra Health Care REIT's average annual revenue forecast for its fiscal year ending in December 2026 is $782.38M, reflecting a 1.00% increase from the reported $774.63M in 2025. The forecast for 2027 is $866.17M, and $914.11M for 2028.

What is Sabra Health Care REIT’s net income forecast?

Sabra Health Care REIT's net income forecast for the fiscal year ending in December 2026 stands at $185.05M, representing an 18.92% increase from the reported $155.61M in 2025. Projections indicate $189.97M in 2027, and $0 in 2028.